JRSIS HEALTH CARE Corp (JRSS) stock: key figures, P/E, revenue and dividend
Health Care · China · ISIN US4662802036
JRSIS HEALTH CARE Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.32 m USD | 320,212.00 USD |
| Gross profit | 274,344.00 USD | 56,068.00 USD |
| Operating income | -486,000.00 USD | 8,171.00 USD |
| Net income | -509,790.00 USD | 8,816.00 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About JRSIS HEALTH CARE Corp
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment. The company was founded in 2018 and is based in Yongzhou, the People's Republic of China.
More stocks
- LogicMark, Inc. (LGMK)
- CLOUDASTRUCTURE, INC. (CSAI)
- Silexion Therapeutics Corp (SLXN)
- Nuvve Holding Corp. (NVVE)
- Appsoft Technologies, Inc. (ASFT)
- GeoVax Labs, Inc. (GOVX)
- POWERCOMPUTE, INC. (PWCM)
- Vocodia Holdings Corp (VHAI)
- DarkPulse, Inc. (DPLS)
- Can B Corp (NASC)
- Onar Holding Corp (ONAR)
- Kairos Pharma, LTD. (KAPA)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.